A blood test can predict metastatic P... - Fight Prostate Ca...

Fight Prostate Cancer

2,956 members1,313 posts

A blood test can predict metastatic PCa outcomes...

Maxone73 profile image
1 Reply

I don't know if I would feel like taking such test, even it I realize its importance to plan for future therapies...

A new blood test called AR-ctDETECT can predict the prognosis for patients with advanced prostate cancer by analyzing circulating tumor DNA (ctDNA).

The test identified ctDNA in 59% of patients with metastatic prostate cancer, and those with detectable ctDNA had significantly worse overall survival compared to those without.

The AR-ctDETECT test focuses on genes relevant to prostate cancer and hormone resistance, including the androgen receptor. The test may help doctors better understand a patient's cancer and personalize treatment plans.

The study, published in Nature Communications, demonstrated that ctDNA detection is associated with worse survival in a phase 3 cohort.

The researchers plan to further explore using the test to predict patient outcomes with specific treatments.

prostatewarriors.com/2024/1...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
dhccpa profile image
dhccpa

At this stage I want to know everything. Lay it on the line, Doc. Maybe I'll get more apprehensive later, but there's too much happening in the PCa world to ignore anything.

Not what you're looking for?

You may also like...

Fish consumption and PCa Mortality. A meta-analysis.

New study below. [1] "In total, 25 prospective cohort studies, recruiting 1,216,474 men, were...
pca2004 profile image

SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic PCa - ARTO II~ Improved response & PFS compared to SOC, MedPage Today, 09/27/23

SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer — Combination...
cujoe profile image

Determinants of PSA Response to Bipolar Androgen Therapy [BAT]

New study from Sartor et al below [1]. "Bipolar Androgen Therapy (BAT) is a novel therapy known to...
pjoshea13 profile image

Predicting Response to Bipolar Androgen Therapy - A Blood Based Biomarker Approach

Recently there has been a number of posts and subsequent responses from members of Fight Prostate...
marnieg46 profile image

Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer

Doctors in Perth, Australia are leading a Phase 3 clinical trial called ProstACT GLOBAL, which is...
Maxone73 profile image